美股期權個股詳情

DGX241220C190000

添加自選

0.07
0.000.00%

延時15分鐘行情收盤價 11/26 16:00 (美東)

0.00最高價0.00最低價

奎斯特診療股票討論

登錄發表評論

ForeverBean

06/01 04:19

$奎斯特診療 (DGX.US)$ PathAI + Invigorate + stable finance + qualified management team + decent PE.
Will it dominate pathology and cancer diagnosis with AI in the future? Worth noting.

Moomoo AI

01/11 05:10

Quest Diagnostics' consistent ROCE and increased capital employed over the past five years suggest steady reinvestment at good returns. This trend, reflected in the stock's strong performance, is expected to continue.

Returns On Capital At Quest Diagnostics (NYSE:DGX) Have Stalled

Moomoo AI

01/08 08:01

The acquisition aligns with Quest's strategy to grow through accretive outreach laboratory acquisitions and expands its ability to serve providers and patients in Ohio and Pennsylvania.

Press Release: Quest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care System

Moomoo AI

2023/12/20 06:39

The CEO of Quest Diagnostics, Jim Davis, believes Yuri Fesko's deep medical expertise and patient-care advocacy will greatly contribute to the company's strategic decisions. His appointment especially bolsters Quest's efforts to improve customer experiences via diagnostic innovations.

Press Release: Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer

Moomoo AI

2023/12/06 04:43

Quest Diagnostics shows favorable metrics with robust reinvestment strategies. Significant earnings growth and an anticipated rise in future ROE, despite a higher payout ratio, hint at other growth factors.

Quest Diagnostics Incorporated's (NYSE:DGX) Stock Has Fared Decently: Is the Market Following Strong Financials?

insider trackerrr

2023/11/08 06:51

Senator Thomas Carper disclosed he profited shorting the US economy.

Since he will be retiring, I wanted to highlight his unusual trading while in Congress for 40 years.
He became a millionaire many times over on a modest federal salary from trading.
Take a look:
Thomas Carper bought 30k in $做空納斯達克100指數ETF-ProShares (PSQ.US)$ , an ultrashort $納指100ETF-Invesco QQQ Trust (QQQ.US)$ index, on July 13 2023.
He hedged/shorted in the past with great results with $AdvisorShares主動股票做空ETF (HDGE.US)$ , ...

逍遥投资派

2023/07/17 04:24

$奎斯特診療 (DGX.US)$5年来营收前4年连续增长，2022年下滑8.4%，5年平均增速为6%，营业利润则在2021年达到23.8亿的高点后，2022年大幅下滑40%，净利润2021年达到20.8亿高点后，2022年大幅下滑51.2%。
2023Q1营收继续下滑10.7%，营业利润大幅下滑40.6%，净利润大幅下滑41.8%。
目前市盈率17.6，市盈率TTM已经提升到20.6，考虑到近期利润大幅萎缩，暂时缺乏吸引力。

FiveHundredCents

2022/08/09 05:09

The White House is about to turn to vaccine producers to curb the spread of monkeypox

The Covid-19 pandemic isn’t over but the U.S. is already entering a new vaccine boom. But the delayed vaccine rollout continues to raise questions. CNN reports that the U.S. delayed a large-scale vaccine order out of fear of the shots expiring before being administered. Federal agencies are exploring new ways to provide vaccines more efficiently, but the supply shortage poses challenges. For the U.S. government,...

Moomoo Breakfast US

2022/07/21 07:44

專欄 Today's pre-market stock movers: TSLA, T, NOK, UAL and more

Gainers:
In reaction to earnings/guidance:
• $超微電腦 (SMCI.US)$ +18%, $諾基亞 (NOK.US)$ +7.7%, $丹納赫 (DHR.US)$ +6.3%, $RLI保險 (RLI.US)$ +5%, $CSX運輸 (CSX.US)$ +4.3%, $金沙集團 (LVS.US)$ +4.2%, $美國鋁業公司 (AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics (STLD.US)$ +2.8%, $Herc Holdings (HRI.US)$ +2.6%, $特斯拉 (TSLA.US)$ +2.5%, $菲利普莫里斯 (PM.US)$ +2.5%, $F.N.B. Corp (FNB.US)$ ...

Moomoo Breakfast US

2022/04/04 07:53

專欄 Today's pre-market stock movers: TWTR, NIU, OCGN, SBUX and more

Gainers
• $Twitter (Delisted) (TWTR.US)$ +20.5% (Elon Musk discloses 9.2% passive stake)
• $康特科技 (CAMT.US)$ +9.6%, $Perion Network (PERI.US)$ +6.6% (In reaction to earnings/guidance)
• $小牛電動 (NIU.US)$ +5% (reports QI sales volume increased 9.4% yr/yr)
• $Iron Spark I Inc (ISAA.US)$ +3.4% (Hypebeast plans to list on NASDAQ through Merger with Iron Spark I)
• $Gatos Silver (GATO.US)$ +2.3% (Provides Bi-Weekly Status Report)
• $Verve Therapeutics (VERV.US)$ +1.8% (re...

暫無評論